All Stories

  1. SEC Injectable Solution Preserves Activated T Cells in Hypothermic Condition
  2. Naproxen and prednisolone reduced intestinal alteration and permeability and bacterial translocation in rat adjuvant-induced arthritis
  3. Editorial: Differential activation of cell death pathways in macrophages as a result of adaptation to divergent microenvironment
  4. Analysis of Gut-Homing Receptors in Circulating Mucosal-Associated Invariant T Cells and Their Presence in Synovial Tissue From Patients With Axial Spondyloarthritis
  5. Fever-range temperature alters continual efferocytosis mediated by mouse proinflammatory macrophages
  6. Metabolic dysregulation in regulatory T cells from patients with immune-mediated glomerular diseases
  7. Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development
  8. HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients’ clinical stage
  9. MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
  10. Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II
  11. Hypothermic Oxygenated Machine Perfusion and Static Cold Storage Drive Distinct Immunomodulation During Liver Transplantation: A Pilot Study
  12. Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment
  13. Corrigendum: Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy
  14. Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergoing Desensitization Therapy
  15. Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells
  16. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy
  17. « Fort comme la mort », où comment l’efferocytose contrôle la résolution de l’inflammation
  18. Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell–Based Approach for the Expansion and Characterization of SARS-CoV-2–Specific T Cells
  19. Plasma citrulline concentration and plasma LPS detection among critically ill patients a prospective observational study
  20. Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors
  21. Melanoma tumour‐derived glycans hijack dendritic cell subsets through C‐type lectin receptor binding
  22. Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell–Driven IL-17 Signature
  23. Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant Transfusion
  24. Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization
  25. Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation
  26. Increased gut permeability and intestinal inflammation precede arthritis onset in the adjuvant-induced model of arthritis
  27. In vivo reprogramming of macrophages using pro-resolving factors to resolve experimental CNS inflammation
  28. Maladie du greffon contre l’hôte
  29. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
  30. Editorial: Hypoxia and inflammation: A two-way street
  31. Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis
  32. Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
  33. Characterization of mucosal‐associated invariant T cells in blood of patients with axial spondyloarthritis and in axial entheses of healthy controls: comment on the article by Rosine et al
  34. Commentary on IL‐34 deficiency impairs FOXP3+ Treg function and decreases immune tolerance homeostasis
  35. Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma
  36. Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
  37. WITHDRAWN: High-throughput preclinical screening of CD123 scFv to design 3rd generation of CAR T-cell in the treatment of BPDCN patient
  38. High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation
  39. Effects of local cryotherapy on systemic endothelial activation, dysfunction, and vascular inflammation in adjuvant-induced arthritis (AIA) rats
  40. Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD
  41. Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells
  42. Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
  43. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates
  44. Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease
  45. NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge
  46. End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?
  47. Mucosal-associated invariant T cells in Giant Cell Arteritis
  48. New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response
  49. NK cells and Lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge
  50. Small Annexin V–Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal Study
  51. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
  52. Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives
  53. Relevance of platelet-derived microvesicles in cirrhosis: The debate remains open
  54. Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
  55. Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
  56. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet
  57. Toward the Characterization of Human Pro-Resolving Macrophages?
  58. Processing methods and storage duration impact extracellular vesicle counts in red blood cell units
  59. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape
  60. Impact of polyclonal antithymocyte globulins on kidney transplant outcomes in real-life: a propensity score analysis
  61. Human primary neutrophil mRNA does not contaminate human resolving macrophage mRNA after efferocytosis
  62. Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation
  63. Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages
  64. CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
  65. Maladie rénale chronique et immunosénescence prématurée : données et perspectives
  66. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
  67. Immune phenotype predicts new onset diabetes after kidney transplantation
  68. Altered thymic CD4+ T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis
  69. End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation
  70. Local ice cryotherapy decreases synovial interleukin 6, interleukin 1β, vascular endothelial growth factor, prostaglandin-E2, and nuclear factor kappa B p65 in human knee arthritis: a controlled study
  71. Long-Term Safety and Efficacy of Single or Repeated Intra-Articular Injection of Allogeneic Neonatal Mesenchymal Stromal Cells for Managing Pain and Lameness in Moderate to Severe Canine Osteoarthritis Without Anti-inflammatory Pharmacological Support:...
  72. MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis?
  73. Factors Produced by Macrophages Eliminating Apoptotic Cells Demonstrate Pro-Resolutive Properties and Terminate Ongoing Inflammation
  74. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients
  75. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia
  76. Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patients
  77. Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis
  78. Antithymocytes globulins: Time to revisit its use in kidney transplantation?
  79. Faculty Opinions recommendation of Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity.
  80. Faculty Opinions recommendation of Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production.
  81. Faculty Opinions recommendation of Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
  82. Faculty Opinions recommendation of Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells.
  83. Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence
  84. Faculty Opinions recommendation of Lxr/apoe activation restricts innate immune suppression in cancer.
  85. Faculty Opinions recommendation of Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.
  86. Faculty Opinions recommendation of Diversification of human plasmacytoid predendritic cells in response to a single stimulus.
  87. Faculty Opinions recommendation of By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation.
  88. Faculty Opinions recommendation of Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
  89. Faculty Opinions recommendation of R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease.
  90. Faculty Opinions recommendation of Missing in action-The meaning of cell death in tissue damage and inflammation.
  91. Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins
  92. Faculty Opinions recommendation of Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.
  93. Faculty Opinions recommendation of Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages.
  94. Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
  95. Faculty Opinions recommendation of Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells.
  96. Faculty Opinions recommendation of RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury.
  97. Posttransplant Immune Activation
  98. Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritis
  99. Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
  100. Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?
  101. Faculty Opinions recommendation of Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice.
  102. Development of a NanoBioAnalytical platform for "on-chip" qualification and quantification of platelet-derived microparticles
  103. Faculty Opinions recommendation of Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity.
  104. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions
  105. Faculty of 1000 evaluation for Cholesterol accumulation in cd11c(+) immune cells is a causal and targetable factor in autoimmune disease.
  106. Faculty of 1000 evaluation for Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide.
  107. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions
  108. Un nouvel éLiXiR pour les cellules dendritiques plasmocytoïdes leucémiques ou dérégulées dans les pathologies inflammatoires
  109. Faculty of 1000 evaluation for Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function.
  110. Faculty of 1000 evaluation for Cutting edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses.
  111. Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia
  112. How to quantify microparticles in RBCs? A validated flow cytometry method allows the detection of an increase in microparticles during storage
  113. Antithymocyte globulins in renal transplantation—from lymphocyte depletion to lymphocyte activation: The doubled-edged sword
  114. Faculty of 1000 evaluation for Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs.
  115. Faculty of 1000 evaluation for Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation.
  116. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
  117. Faculty of 1000 evaluation for Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.
  118. Faculty of 1000 evaluation for Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
  119. Faculty of 1000 evaluation for Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans.
  120. Faculty Opinions recommendation of Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans.
  121. Faculty of 1000 evaluation for Apoptosis in response to microbial infection induces autoreactive TH17 cells.
  122. Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects
  123. Faculty of 1000 evaluation for Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-Versus-Host Disease in Mice.
  124. Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy
  125. Involvement and prognosis value of CD8 + T cells in giant cell arteritis
  126. Faculty of 1000 evaluation for Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
  127. Faculty of 1000 evaluation for Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.
  128. Faculty of 1000 evaluation for Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization.
  129. Faculty of 1000 evaluation for Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity.
  130. Plasmacytoid Dendritic Cells Die by the CD8 T Cell–Dependent Perforin Pathway during Acute Nonviral Inflammation
  131. Faculty of 1000 evaluation for Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.
  132. Faculty of 1000 evaluation for Bridging channel dendritic cells induce immunity to transfused red blood cells.
  133. Faculty of 1000 evaluation for Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces.
  134. Faculty of 1000 evaluation for A blast without power - cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responses.
  135. Pre‐transplant end‐stage renal disease‐related immune risk profile in kidney transplant recipients predicts post‐transplant infections
  136. Faculty of 1000 evaluation for Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.
  137. Pretransplant thymic function predicts acute rejection in antithymocyte globulin–treated renal transplant recipients
  138. Faculty of 1000 evaluation for Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
  139. Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
  140. Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival
  141. Concise Review: Apoptotic Cell-Based Therapies-Rationale, Preclinical Results and Future Clinical Developments
  142. Faculty of 1000 evaluation for Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.
  143. Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles
  144. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10
  145. Faculty of 1000 evaluation for Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance.
  146. Faculty of 1000 evaluation for Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.
  147. Vitreous Microparticle Shedding in Retinal Detachment: A Prospective Comparative Study
  148. Interleukin-22 modulating properties in graft-versus-host disease
  149. Faculty of 1000 evaluation for Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage.
  150. The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation
  151. Faculty of 1000 evaluation for Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1.
  152. Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
  153. New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
  154. Faculty of 1000 evaluation for Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.
  155. Faculty of 1000 evaluation for Phagocytosis of apoptotic cells in homeostasis.
  156. Faculty of 1000 evaluation for Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation.
  157. Faculty of 1000 evaluation for CELL DEATH. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.
  158. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis
  159. Tips and tricks for flow cytometry-based analysis and counting of microparticles
  160. Cellules apoptotiques et prévention de l’allo-immunisation érythrocytaire
  161. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease
  162. The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1
  163. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3–positive CD8+ T lymphocytes
  164. Implications cliniques de l’immunosénescence dans les maladies rénales chroniques
  165. Faculty of 1000 evaluation for Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling.
  166. Faculty of 1000 evaluation for A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury.
  167. Transforming growth factor-β released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation
  168. ATG-Induced Accelerated Immune Senescence: Clinical Implications in Renal Transplant Recipients
  169. Faculty of 1000 evaluation for Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production.
  170. Faculty of 1000 evaluation for Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.
  171. Oridonin's therapeutic effect: Suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease
  172. Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation
  173. T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1
  174. Faculty of 1000 evaluation for Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.
  175. Effects of anti-TNF-αagents on circulating endothelial-derived and platelet-derived microparticles in psoriasis
  176. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
  177. Faculty of 1000 evaluation for B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets.
  178. In vitro study of the impact of mechanical tension on the dermal fibroblast phenotype in the context of skin wound healing
  179. Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
  180. Faculty of 1000 evaluation for Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.
  181. Faculty of 1000 evaluation for Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.
  182. Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function
  183. Faculty of 1000 evaluation for Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.
  184. Faculty of 1000 evaluation for In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
  185. Faculty of 1000 evaluation for Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
  186. Faculty of 1000 evaluation for Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.
  187. Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: Lack of lymphocyte recovery as a major contributing factor
  188. Polyclonal Antithymocyte Globulin and Cardiovascular Disease in Kidney Transplant Recipients
  189. Faculty of 1000 evaluation for Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.
  190. Faculty of 1000 evaluation for Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells.
  191. Faculty of 1000 evaluation for Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia.
  192. Faculty of 1000 evaluation for Unexpected link between an antibiotic, pannexin channels and apoptosis.
  193. Faculty of 1000 evaluation for Apoptotic cell clearance: basic biology and therapeutic potential.
  194. Faculty of 1000 evaluation for Concepts of tissue injury and cell death in inflammation: a historical perspective.
  195. Faculty of 1000 evaluation for The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids.
  196. Mécanismes immunologiques impliqués dans la thrombopénie immunologique résistante au rituximab
  197. A skin substitute based on human amniotic membrane
  198. Faculty of 1000 evaluation for Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection.
  199. Can leg ulcer fibroblasts phenotype be influenced by human amniotic membrane extract?
  200. Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood
  201. Faculty of 1000 evaluation for Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis.
  202. Increased Levels of Circulating Microparticles Are Associated with Increased Procoagulant Activity in Patients with Cutaneous Malignant Melanoma
  203. Faculty of 1000 evaluation for ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
  204. Faculty of 1000 evaluation for Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
  205. Preferential splenic CD8+ T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia
  206. Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases
  207. Faculty of 1000 evaluation for Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice.
  208. Faculty of 1000 evaluation for The Nlrp3 inflammasome regulates acute graft-versus-host disease.
  209. Faculty of 1000 evaluation for Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids.
  210. Faculty of 1000 evaluation for The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis.
  211. Faculty of 1000 evaluation for Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota.
  212. Faculty of 1000 evaluation for Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
  213. Faculty of 1000 evaluation for Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation.
  214. Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone
  215. Faculty of 1000 evaluation for Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion.
  216. Interleukine 22
  217. Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry
  218. Faculty of 1000 evaluation for Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance.
  219. Faculty of 1000 evaluation for Specialized role of migratory dendritic cells in peripheral tolerance induction.
  220. Faculty of 1000 evaluation for Intestinal macrophages: well educated exceptions from the rule.
  221. Faculty of 1000 evaluation for Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells.
  222. L14. Immunomodulatory properties of apoptotic cells
  223. Proteinase 3 (PR3) is a phosphatidylserine-binding protein that can bind microparticles: Relevance in the context of granulomatosis with polyangiitis (GPA)
  224. Influence of Fractalkine Receptor Gene Polymorphisms V249I-T280M on Cancer Occurrence After Renal Transplantation
  225. Faculty of 1000 evaluation for Human inflammatory dendritic cells induce Th17 cell differentiation.
  226. Subclinical Epstein–Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences
  227. Faculty of 1000 evaluation for The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes.
  228. Cytomegalovirus Exposure and Cardiovascular Disease in Kidney Transplant Recipients
  229. CD4 T Lymphopenia, Thymic Function, Homeostatic Proliferation and Late Complications Associated with Kidney Transplantation
  230. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect
  231. Faculty of 1000 evaluation for Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes.
  232. Faculty of 1000 evaluation for Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation.
  233. Can Allogeneic Hematopoietic Cell Transplantation Outcome be Improved by Intravenous Apoptotic Cell Infusion?
  234. Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study
  235. Faculty of 1000 evaluation for Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.
  236. Faculty of 1000 evaluation for HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.
  237. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells
  238. Erratum to “Blood product and host: A potentially inflamed relationship?” [Trans Clin Biol 19 (3) (2012) 81–3]
  239. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
  240. Faculty of 1000 evaluation for T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.
  241. Faculty of 1000 evaluation for Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.
  242. Faculty of 1000 evaluation for T cells become licensed in the lung to enter the central nervous system.
  243. Faculty of 1000 evaluation for Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury.
  244. Faculty of 1000 evaluation for Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice.
  245. Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients
  246. Faculty of 1000 evaluation for Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.
  247. Faculty of 1000 evaluation for Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.
  248. Faculty of 1000 evaluation for Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.
  249. Faculty of 1000 evaluation for Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles.
  250. Intracytoplasmic detection of TCL1—but not ILT7—by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis
  251. Polymorphismes génétiques : comment interpréter les études ?
  252. Blood product and host: An inflamed relationship!
  253. Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?
  254. Faculty of 1000 evaluation for Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance.
  255. Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
  256. Faculty of 1000 evaluation for Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.
  257. Faculty of 1000 evaluation for Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans.
  258. Faculty of 1000 evaluation for Interleukin-22 drives endogenous thymic regeneration in mice.
  259. Faculty of 1000 evaluation for Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis.
  260. Développement d’un syndrome de Gougerot-Sjögren primitif après administration de vaccin antigrippal A/H1N1. Commentaire de l’article de F. Tabache et al. « Polyarthrite aiguë après vaccination antigrippale A/H1N1 », Joint Bone Spine, 2011, doi:10.1016/...
  261. Faculty of 1000 evaluation for Plasmacytoid dendritic cells control T-cell response to chronic viral infection.
  262. Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease
  263. Faculty of 1000 evaluation for Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo.
  264. Faculty of 1000 evaluation for MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice.
  265. Faculty of 1000 evaluation for Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells.
  266. Faculty of 1000 evaluation for Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens.
  267. Functions of TGF-β-Exposed Plasmacytoid Dendritic Cells
  268. Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: The centrifugation step matters!
  269. Comments on the article by Tabache F. et al. “Acute polyarthritis after influenza A H1N1 immunization”, Joint Bone Spine, 2011, doi:10.1016/j.jbs.2011.02.007: Primary Sjögren's syndrome occurring after influenza A H1N1 vaccine administration
  270. Faculty of 1000 evaluation for Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.
  271. CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry
  272. The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins
  273. Faculty Opinions recommendation of The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells.
  274. Faculty of 1000 evaluation for Peripheral education of the immune system by colonic commensal microbiota.
  275. Faculty of 1000 evaluation for The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.
  276. Development and characterization of a human dermal equivalent with physiological mechanical properties
  277. Immune Monitoring of Kidney Recipients: Biomarkers to Appreciate Immunosuppression -Associated Complications
  278. Faculty of 1000 evaluation for Control of TH17 cells occurs in the small intestine.
  279. Faculty of 1000 evaluation for Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair.
  280. Faculty of 1000 evaluation for Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
  281. Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation
  282. Faculty of 1000 evaluation for Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.
  283. Faculty of 1000 evaluation for In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.
  284. Increased Levels of Circulating Endothelial-Derived Microparticles and Small-Size Platelet-Derived Microparticles in Psoriasis
  285. Thymic function, anti-thymocytes globulins, and cancer after renal transplantation
  286. Faculty of 1000 evaluation for Hemophagocytosis causes a consumptive anemia of inflammation.
  287. Faculty of 1000 evaluation for Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.
  288. Faculty of 1000 evaluation for Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy.
  289. TGF-β–Exposed Plasmacytoid Dendritic Cells Participate in Th17 Commitment
  290. Faculty of 1000 evaluation for Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
  291. Faculty of 1000 evaluation for Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
  292. Faculty of 1000 evaluation for IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.
  293. Faculty of 1000 evaluation for The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.
  294. Faculty of 1000 evaluation for Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.
  295. Faculty of 1000 evaluation for alphaV Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice.
  296. Faculty of 1000 evaluation for Expression of alphavbeta8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice.
  297. TheInterleukin-6Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
  298. Faculty of 1000 evaluation for Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
  299. Faculty of 1000 evaluation for Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
  300. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level
  301. Faculty of 1000 evaluation for Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.
  302. Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome
  303. Faculty of 1000 evaluation for Gamma-delta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism.
  304. Faculty of 1000 evaluation for Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model.
  305. Faculty of 1000 evaluation for MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.
  306. Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism at Position −765 on Skin Cancer after Renal Transplantation
  307. Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome
  308. Prolonged CD4 T Cell Lymphopenia Increases Morbidity and Mortality after Renal Transplantation
  309. Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases
  310. Les microparticules endothéliales
  311. Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism −765 on Graft Loss After Renal Transplantation
  312. G-765C COX-2 Gene Promoter Polymorphism and Risk of Atherosclerosis After Kidney Transplantation
  313. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases
  314. Lethal Effect of CD3-Specific Antibody in Mice Deficient in TGF-β1 by Uncontrolled Flu-Like Syndrome
  315. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
  316. « Mort sur ordonnance » ou comment l’anticorps anti-CD3 utilise l’apoptose pour induire la tolérance
  317. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity
  318. Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?
  319. Functionally fused antibodies—A novel adjuvant fusion system
  320. Vers l’utilisation thérapeutique de l’administration intraveineuse de leucocytes apoptotiques du donneur en thérapie cellulaire ?
  321. CD3-specific antibody–induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells
  322. Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process
  323. Surveillance biologique des patients transplantés rénaux : vers une prévision des complications associées à l’immunosuppression ?
  324. Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4 + CD25 high FOXP3 + Regulato...
  325. Lymphocyte Subsets in Renal Transplant Recipients with de novo Genitourinary Malignancies
  326. Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction
  327. Preventive Effect of Ultraviolet Radiation on Murine Chronic Sclerodermatous Graft-Versus-Host Disease
  328. Role of STAT3 in CD4+CD25+FOXP3+ Regulatory Lymphocyte Generation: Implications in Graft-versus-Host Disease and Antitumor Immunity
  329. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis
  330. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study
  331. Mediators Involved in the Immunomodulatory Effects of Apoptotic Cells
  332. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25– T lymphocytes
  333. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
  334. Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study
  335. Erratum
  336. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection*
  337. IL-6 Promoter Polymorphism −174 Is Associated with New-Onset Diabetes after Transplantation
  338. No Evidence of Association between NOD2/CARD15 Gene Polymorphism and Atherosclerotic Events after Renal Transplantation
  339. Association of Mixed Hematopoietic Chimerism with Elevated Circulating Autoantibodies and Chronic Graft-versus-Host Disease Occurrence
  340. Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies
  341. Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients
  342. Eighteen days of “living high, training low” stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners
  343. Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion
  344. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation
  345. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation
  346. B Cell Allogeneic Responses after Hematopoietic Cell Transplantation: Is It Time to Address this Issue?
  347. A single-platform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow transplantation
  348. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
  349. Intravenous Infusion of Apoptotic Cells Simultaneously with Allogeneic Hematopoietic Grafts Alters Anti-Donor Humoral Immune Responses
  350. INTRAVENOUS INFUSION OF APOPTOTIC CELLS SIMULTANEOUSLY WITH ALLOGENEIC HEMATOPOIETIC GRAFT ALTERS ANTI-DONOR HUMORAL IMMUNE RESPONSES
  351. Immune regulation and transplantation: an exciting challenge.1
  352. A Single Intravenous Infusion of Apoptotic Cells, An Alternative Cell-Based Therapy Approach Facilitating Hematopoietic Cell Engraftment, Did Not Induce Autoimmunity
  353. Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?
  354. How should chimerism be decoded?1
  355. Administration of donor apoptotic cells: an alternative cell-based therapy to induce tolerance?1
  356. Immunothérapie adoptive allogénique
  357. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies
  358. CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant Recipients
  359. Death receptors on reactive astrocytes
  360. LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level
  361. Influence of Ex Vivo Expansion and Retrovirus-Mediated Gene Transfer on Primary T Lymphocyte Phenotype and Functions
  362. A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2
  363. Polybrene and interleukin‐4: two opposing factors for retroviral transduction of bone‐marrow‐derived dendritic cells
  364. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation
  365. Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction
  366. DENDRITIC CELLS: TO WHERE DO THEY LEAD?
  367. Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway
  368. Enhanced activation of B cells in a granulocyte colony‐stimulating factor‐mobilized peripheral blood stem cell graft
  369. Autocrine regulation of cord blood–derived human mast cell activation by IL-10☆
  370. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers
  371. Distinct hematopoietic support by two human stromal cell lines
  372. Inhibition of IgE‐induced activation of human mast cells by IL‐10
  373. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells
  374. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
  375. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation
  376. TWEAK stimulation of astrocytes and the proinflammatory consequences
  377. TWEAK stimulation of astrocytes and the proinflammatory consequences
  378. Tumor expression of Fas ligand (CD95L) and the consequences